230 related articles for article (PubMed ID: 29198634)
1. Intraoperative Administration of 4-Factor Prothrombin Complex Concentrate Reduces Blood Requirements in Cardiac Transplantation.
Sun GH; Patel V; Moreno-Duarte I; Zahedi F; Ursprung E; Couper G; Chen FY; Welsby IJ; Comenzo R; Kao G; Cobey FC
J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):161-167. PubMed ID: 29198634
[TBL] [Abstract][Full Text] [Related]
2. Prothrombin Complex Concentrates for Warfarin Reversal Before Heart Transplantation.
Wanek MR; Hodges K; Persaud RA; Lam SW; Soltesz EG; Tong MZ; Moazami N
Ann Thorac Surg; 2019 May; 107(5):1409-1415. PubMed ID: 30476474
[TBL] [Abstract][Full Text] [Related]
3. Prothrombin Complex Concentrate Reduces Blood Product Utilization in Heart Transplantation.
Enter DH; Zaki AL; Marsh M; Cool N; Kruse J; Li Z; Andrei AC; Iddriss A; McCarthy PM; Malaisrie SC; Anderson A; Rich JD; Pham DT
Pharmacotherapy; 2017 Oct; 37(10):1215-1220. PubMed ID: 28833357
[TBL] [Abstract][Full Text] [Related]
4. Impact of Prothrombin Complex Concentrate on Blood Use, Cost, and Outcomes in Heart Transplantation.
Wu DW; Xia Y; Uelinger J; Forest S; Szymanski J; Mohandas K; Walsh R; Karim S; Marks E; Himchak E; Gupta R; Goldstein D
Ann Thorac Surg; 2018 Apr; 105(4):1152-1157. PubMed ID: 29397934
[TBL] [Abstract][Full Text] [Related]
5. Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices.
Rimsans J; Levesque A; Lyons E; Sylvester K; Givertz MM; Mehra MR; Stewart GC; Connors JM
J Thromb Thrombolysis; 2018 Aug; 46(2):180-185. PubMed ID: 29785470
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Early Administration of 4-Factor Prothrombin Complex Concentrate in Patients With Trauma at Risk of Massive Transfusion: The PROCOAG Randomized Clinical Trial.
Bouzat P; Charbit J; Abback PS; Huet-Garrigue D; Delhaye N; Leone M; Marcotte G; David JS; Levrat A; Asehnoune K; Pottecher J; Duranteau J; Courvalin E; Adolle A; Sourd D; Bosson JL; Riou B; Gauss T; Payen JF;
JAMA; 2023 Apr; 329(16):1367-1375. PubMed ID: 36942533
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation.
Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A
Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427
[TBL] [Abstract][Full Text] [Related]
8. 4-Factor Prothrombin Complex Concentrate (PCC4, Kcentra®) Protocol Reduces Blood Requirements for Heart Transplantation: A Novel Protocol.
Pratt Cleary J; Hodge L; Palmer B; Barreiro CJ; Ingemi A
Ann Transplant; 2016 Aug; 21():531-7. PubMed ID: 27558534
[TBL] [Abstract][Full Text] [Related]
9. Prothrombin Complex Concentrate for Warfarin Reversal in Patients with Continuous-Flow Left Ventricular Assist Devices: A Narrative Review.
Jennings DL; Rimsans J; Connors JM
ASAIO J; 2020 May; 66(5):482-488. PubMed ID: 31192853
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative prothrombin complex concentrate administration and outcomes in patients undergoing left ventricular assist device implantation.
Boswell MR; Stulak JM; Tchantchaleishvili V; Weber MP; Warner MA; Smith BB; Smith MM
Artif Organs; 2021 Aug; 45(8):E223-E303. PubMed ID: 33469913
[TBL] [Abstract][Full Text] [Related]
11. Four-factor prothrombin complex concentrate in adjunct to whole blood in trauma-related hemorrhage: Does whole blood replace the need for factors?
Khurrum M; Ditillo M; Obaid O; Anand T; Nelson A; Chehab M; Kitts DJ; Douglas M; Bible L; Joseph B
J Trauma Acute Care Surg; 2021 Jul; 91(1):34-39. PubMed ID: 33843830
[TBL] [Abstract][Full Text] [Related]
12. Impact of intraoperative factor concentrates on blood product transfusions during orthotopic liver transplantation.
Colavecchia AC; Cohen DA; Harris JE; Thomas JM; Lindberg S; Leveque C; Salazar E
Transfusion; 2017 Dec; 57(12):3026-3034. PubMed ID: 28960322
[TBL] [Abstract][Full Text] [Related]
13. Prothrombin Complex Concentrate vs Plasma for Post-Cardiopulmonary Bypass Coagulopathy and Bleeding: A Randomized Clinical Trial.
Smith MM; Schroeder DR; Nelson JA; Mauermann WJ; Welsby IJ; Pochettino A; Montonye BL; Assawakawintip C; Nuttall GA
JAMA Surg; 2022 Sep; 157(9):757-764. PubMed ID: 35767271
[TBL] [Abstract][Full Text] [Related]
14. Use of four-factor prothrombin complex concentrate (4F-PCC) for management of bleeding not associated with therapeutic anticoagulant use.
Uttaro E; Young MR; Falvey J; Corvelli JM; Acquisto NM
Transfus Apher Sci; 2023 Oct; 62(5):103759. PubMed ID: 37453907
[TBL] [Abstract][Full Text] [Related]
15. A new kid on the block: Outcomes with Kcentra 1 year after approval.
Berndtson AE; Huang WT; Box K; Kobayashi L; Godat LN; Smith AM; Weingarten D; Coimbra R
J Trauma Acute Care Surg; 2015 Dec; 79(6):1004-8. PubMed ID: 26488322
[TBL] [Abstract][Full Text] [Related]
16. Thromboembolic Risk of 4-Factor Prothrombin Complex Concentrate versus Fresh Frozen Plasma for Urgent Warfarin Reversal in the Emergency Department.
Maguire M; Fuh L; Goldstein JN; Marshall AL; Levine M; Howell ML; Parry BA; Rosovsky R; Hayes BD
West J Emerg Med; 2019 Jul; 20(4):619-625. PubMed ID: 31316701
[TBL] [Abstract][Full Text] [Related]
17. Is there a difference in efficacy, safety, and cost-effectiveness between 3-factor and 4-factor prothrombin complex concentrates among trauma patients on oral anticoagulants?
Mangram A; Oguntodu OF; Dzandu JK; Hollingworth AK; Hall S; Cung C; Rodriguez J; Yusupov I; Barletta JF
J Crit Care; 2016 Jun; 33():252-6. PubMed ID: 27021851
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the safety and efficacy between 3-factor and 4-factor prothrombin complex concentrates for the reversal of warfarin.
Kuroski JE; Young S
Am J Emerg Med; 2017 Jun; 35(6):871-874. PubMed ID: 28161220
[TBL] [Abstract][Full Text] [Related]
19. The use of prothrombin complex concentrate as a warfarin reversal agent in pediatric patients undergoing orthotopic heart transplantation.
Sisti DJ; Williams GD; Ding V; Long J; Maeda K; Chen S; Navaratnam M
Paediatr Anaesth; 2020 May; 30(5):564-570. PubMed ID: 32037665
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Temporary Warfarin Reversal in Patients With Left Ventricular Assist Devices: the KVAD Study.
Sylvester KW; Grandoni J; Rhoten M; Coakley L; Matiello-Lyons E; Frankel K; Fortin B; Jolley K; Park HS; Freedman RY; Mehra MR; Givertz MM; Connors JM
J Card Fail; 2024 Mar; ():. PubMed ID: 38521486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
